Link to this page
Biological and Environmental Research Ontology
| Preferred Name | ceftaroline fosamil | |
| Synonyms |
ceftarolina fosamilo ceftaroline fosamil ceftarolinum fosamilum (6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-3,4-didehydrocepham-4-carboxylate |
|
| Definitions |
A cephalosporin having [4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl and {(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino side groups located at positions 3 and 7 respectively. The N-phospho prodrug of ceftaroline, a broad-spectrum antibiotic active against methicillin-resistant Staphylococcus aureus (MRSA). It is used for the treatment of adults with acute bacterial skin and skin structure infections. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_70718 |
|
| alternative term |
ceftarolina fosamilo ceftaroline fosamil ceftarolinum fosamilum (6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-3,4-didehydrocepham-4-carboxylate
|
|
| bearer of | ||
| charge |
0
|
|
| database_cross_reference |
PMID:21482570 PMID:21897727 PMID:22779432 PMID:21393213 CAS:229016-73-3 Reaxys:9535806 Patent:MX2012003411 PMID:22594846 PMID:22330908 Wikipedia:Ceftaroline_fosamil PMID:21076711 PMID:21252841 PMID:21548186 PMID:21482565 PMID:21482566 PMID:21482568 PMID:29017833 PMID:21115454 PMID:21115455 PMID:21115453 PMID:21115456 Drug_Central:4169 PMID:22314524 PMID:22903949 PMID:22355258 PMID:21162631 PMID:22058102 PMID:22985880 PMID:22354289
|
|
| definition |
A cephalosporin having [4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl and {(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino side groups located at positions 3 and 7 respectively. The N-phospho prodrug of ceftaroline, a broad-spectrum antibiotic active against methicillin-resistant Staphylococcus aureus (MRSA). It is used for the treatment of adults with acute bacterial skin and skin structure infections.
|
|
| formula |
C22H21N8O8PS4
|
|
| has_exact_synonym |
7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-3,4-didehydrocepham-4-carboxylate
|
|
| has_functional_parent | ||
| has_obo_namespace |
chebi_ontology
|
|
| has_related_synonym |
ceftarolina fosamilo ceftaroline fosamil ceftarolinum fosamilum (6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
| id |
CHEBI:70718
|
|
| in_subset | ||
| inchi |
InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13-/t14-,19-/m1/s1
|
|
| inchikey |
ZCCUWMICIWSJIX-NQJJCJBVSA-N
|
|
| label |
ceftaroline fosamil
|
|
| mass |
684.68500
|
|
| monoisotopicmass |
684.01028
|
|
| notation |
CHEBI:70718
|
|
| prefLabel |
ceftaroline fosamil
|
|
| RO_0000087 | ||
| smiles |
[H][C@]12SCC(Sc3nc(cs3)-c3cc[n+](C)cc3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\c1nsc(NP(O)(O)=O)n1)C([O-])=O
|
|
| subClassOf |
http://purl.obolibrary.org/obo/CHEBI_23066 http://purl.obolibrary.org/obo/CHEBI_36816 http://purl.obolibrary.org/obo/CHEBI_38099 http://purl.obolibrary.org/obo/CHEBI_38418 |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |